Business, energy, technology, markets and global industry news from Business News Today

New Jersey

PharmaDeviceNews New Jersey
Representative image: Aptar Pharma’s FDA-funded research into next-generation propellants highlights the scientific complexity behind greener metered-dose inhalers, where aerosol performance, device design and bioequivalence testing could shape the future of respiratory drug delivery.
Pharma & Biotech

Aptar Pharma just removed a critical development barrier for complex nasal drugs. How much could change?

Aptar Pharma expands DEA-authorised controlled-substance development services. See how the move could simplify nasal and inhaled drug programmes.

Read More
Johnson & Johnson’s proposed $5.5 billion settlement aims to resolve about 76,000 existing ovarian talc litigation claims, subject to the required claimant participation. Representative image.
Pharma & Biotech

Could Johnson & Johnson’s $5.5bn talc deal finally close a 15-year legal overhang?

Johnson & Johnson proposes a $5.5 billion deal for 76,000 ovarian talc claims, but participation, future lawsuits and costs remain critical.

Read More
Representative image of a modern endoscopy warehouse and service center, illustrating how Fujifilm’s Fairfield expansion could strengthen U.S. device logistics, repair capacity and hospital support.
Medical Devices & Diagnostics

Fujifilm scales New Jersey operations as ELUXEO and therapeutic scope adoption grows

See why Fujifilm’s new endoscopy warehouse could strengthen service capacity, device uptime and U.S. hospital growth. Read the full analysis.

Read More